Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.
about
Inhibition of cathepsin B activity attenuates extracellular matrix degradation and inflammatory breast cancer invasionLoss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancersStromal cell expression of caveolin-1 predicts outcome in breast cancerAn absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancersIdentification of rifampin-regulated functional modules and related microRNAs in human hepatocytes based on the protein interaction networkMembrane progesterone receptor alpha as a potential prognostic biomarker for breast cancer survival: a retrospective studyThe High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.Involvement of Caveolin-1 in repair of DNA damage through both homologous recombination and non-homologous end joiningNovel strategies to enforce an epithelial phenotype in mesenchymal cells.Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathwayAbsence of the caveolin-1 P132L mutation in cancers of the breast and other organs.Molecular insights on basal-like breast cancer.Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq dataCathepsin B: a potential prognostic marker for inflammatory breast cancerHost deficiency in caveolin-2 inhibits lung carcinoma tumor growth by impairing tumor angiogenesis.Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma.Cell surface heparan sulfate proteoglycans control adhesion and invasion of breast carcinoma cells.RNA-Seq gene profiling--a systematic empirical comparison.Role of caveolin-2 in subcutaneous tumor growth and angiogenesis associated with syngeneic mouse Lewis lung carcinoma and B16 melanoma modelsElevated PI3K signaling drives multiple breast cancer subtypes.Novel insights into the role of caveolin-2 in cell- and tissue-specific signaling and function.Shortening of 3'UTRs correlates with poor prognosis in breast and lung cancer.A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypesCaveolin-1 expression is elevated in claudin-low mammary tumor cells.Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease.Basal breast cancer: a complex and deadly molecular subtypeLunatic fringe deficiency cooperates with the Met/Caveolin gene amplicon to induce basal-like breast cancer.Determination of whole transcription profiles and specific pathways in invasive ductal breast carcinomaAn in vivo model of epithelial to mesenchymal transition reveals a mitogenic switch.CpG island shore methylation regulates caveolin-1 expression in breast cancerProteomic profiling of lipid rafts in a human breast cancer model of tumorigenic progression.Biomarkers for Basal-like Breast Cancer.Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis.Statins and breast cancer: may matrix metalloproteinase be the missing link.MMTV promoter-regulated caveolin-1 overexpression yields defective parenchymal epithelia in multiple exocrine organs of transgenic mice.The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.Pharmacotherapy of triple-negative breast cancer.Adjuvant therapy of triple negative breast cancer.Molecular markers for breast cancer: prediction on tumor behavior.Induced p53 loss in mouse luminal cells causes clonal expansion and development of mammary tumours.
P2860
Q22000757-08FB0105-470D-45F0-B103-A166070412D7Q24620397-62DEBEF3-4932-4055-A2BF-F38A1F0712D1Q24658345-B1FDC7E2-6F1F-4F91-8648-147624D99C68Q24658358-8A83FAB0-A5BF-4053-A5D5-3129DBC2BA9DQ28597149-636CC6EC-3696-4E6C-933B-91A165097E03Q28730745-ADA41237-BA8F-4DBE-B819-8CAFDB639BF2Q33613335-E1ACA012-60A3-4F1B-AE4A-E6F348F61B30Q33654095-709986F2-3125-4F1C-AFA1-6376294349B4Q33916905-F693A2AE-FD4E-4A33-9102-010605A29117Q34048106-44151346-3314-4E1F-8D93-A92F92AD076EQ34084878-A2941A55-6A77-47D1-9463-B57BC7D075C9Q34123314-DC240C13-602E-4E45-94AD-82A28FEC9473Q34356351-7DEE904A-C088-4C3B-8876-929257C5E11BQ34499322-05DAA97F-0CE5-415B-88B7-1FAF1C2127E2Q34518452-8EFFFDFE-4003-4682-9012-5DB9CCB9467EQ35032590-72E1EF74-DFF5-47EA-B6E8-27F4A4DB7AF8Q35078198-843F3518-33C7-4ECD-8C6D-B46A5F852B84Q35288892-6EA8ABA7-6AAF-464A-B974-178DD70F81B2Q35636901-9179D2D7-AB6C-44F9-B1D2-3AB2D948104FQ35640263-EA1E3263-676D-417A-96E9-98B5A989D7F5Q35645798-21BA99D8-13D2-4CDD-BFAA-99E42CD057F7Q35745093-0DCA1153-BA28-4C75-8209-95B6EB62DC79Q35832269-316E60B8-002A-425D-8554-3CD925BDEEC3Q35834041-D81A4613-5EBC-4B1B-B50A-C8DC6199DA41Q35910859-833C7198-B59B-4970-884B-C7B5DC981886Q35931900-67B28F21-4C9F-4D62-92E6-D54A859B884DQ36702175-AF575615-574B-4EB9-AFB4-55610EA12CABQ36853431-6714EF99-B3A1-40B3-A8BC-8D2CB369BACAQ36994700-E372A91D-764D-4868-9ACA-41244BC47BC5Q37209244-6B111863-3B5F-4E66-982C-9A8A9275E927Q37307440-F5BC6582-2775-4D4D-99B7-618B5077AF69Q37328394-D3A9F60C-1096-4021-88D3-D7801EF8434AQ37338128-3AB489C9-2808-44B9-8FC4-E4446D7F40A4Q37393969-B6898220-3DDC-4A5C-A57A-B12E0381A960Q37436585-EE970E44-3127-43F4-9F3B-0C5766997265Q37492303-959EC134-01DE-4F79-B4CA-F0995548123DQ37565645-E79886CA-0FF6-4F6D-AB93-52E69E58749BQ37571648-9EBDA7C8-0E52-4B59-BC70-96CFE6AB672FQ37586753-86135E89-F798-431C-BF6A-BA40BF77955AQ37651843-E3F609BC-9AC0-4D09-99E1-3907EBB96D5B
P2860
Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Caveolin 1 and Caveolin 2 are ...... iple-negative immunophenotype.
@en
type
label
Caveolin 1 and Caveolin 2 are ...... iple-negative immunophenotype.
@en
prefLabel
Caveolin 1 and Caveolin 2 are ...... iple-negative immunophenotype.
@en
P2093
P2860
P50
P356
P1476
Caveolin 1 and Caveolin 2 are ...... riple-negative immunophenotype
@en
P2093
J S Reis-Filho
S E Elsheikh
P2860
P2888
P304
P356
10.1038/SJ.BJC.6604463
P407
P577
2008-07-08T00:00:00Z